Literature DB >> 9100226

Phorbol esters affect multiple steps in beta-amyloid precursor protein trafficking and amyloid beta-protein production.

E H Koo1.   

Abstract

BACKGROUND: Amyloid beta-protein (A beta), the major constituent of amyloid deposits found in Alzheimer's disease, is derived from the beta-amyloid precursor protein (beta PP). Constitutive proteolysis by alpha-secretase and secretion of soluble beta PP (beta PPs) are stimulated by protein kinase C (PKC) activation, whereas A beta production and release are inhibited. The cellular mechanism that underlies the PKC-mediated down-regulation of A beta generation is unclear. Because endocytic processing of beta PP from the cell surface is a major pathway of A beta production, the effect of PKC activation by phorbol 12,13-dibutyrate (PDBu) on endocytic trafficking of beta PP was examined.
MATERIALS AND METHODS: In this study, trafficking of beta PP was assayed in Chinese hamster ovary cells (CHO) cells stably transfected with full-length beta PP751.
RESULTS: Treatment with PDBu resulted in a rapid and striking reduction of up to 80% in the amount of beta PP at the cell surface. This loss of cell-surface molecules could not be accounted for by changes in the trafficking of cell-surface beta PP molecules, as determined by a radiolabeled antibody assay. Rather, the decrease in beta PP was due primarily to a reduction in the sorting of beta PP to the cell surface. This alteration was correlated with accelerated intracellular alpha-secretase-mediated beta PP cleavage and accelerated beta PP trafficking in the exocytic pathway.
CONCLUSIONS: The data suggest that the displacement of beta PP away from the cell surface after phorbol ester treatment reduces the substrate available for endocytic processing and in turn, results in the inhibition of A beta production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9100226      PMCID: PMC2230050     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  21 in total

1.  Enhanced release of amyloid beta-protein from codon 670/671 "Swedish" mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways.

Authors:  R G Perez; S L Squazzo; E H Koo
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

Review 2.  Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease.

Authors:  F Checler
Journal:  J Neurochem       Date:  1995-10       Impact factor: 5.372

3.  Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein.

Authors:  H Xu; P Greengard; S Gandy
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

4.  Reversal of the Swedish familial Alzheimer's disease mutant phenotype in cultured cells treated with phorbol 12,13-dibutyrate.

Authors:  K M Felsenstein; K M Ingalls; L W Hunihan; S B Roberts
Journal:  Neurosci Lett       Date:  1994-06-20       Impact factor: 3.046

5.  Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.

Authors:  C F Simmons; A L Schwartz
Journal:  Mol Pharmacol       Date:  1984-11       Impact factor: 4.436

6.  Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture.

Authors:  M B Podlisny; B L Ostaszewski; S L Squazzo; E H Koo; R E Rydell; D B Teplow; D J Selkoe
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

7.  Production of Alzheimer 4kDa beta-amyloid peptide requires the C-terminal cytosolic domain of the amyloid precursor protein.

Authors:  A C LeBlanc; P Gambetti
Journal:  Biochem Biophys Res Commun       Date:  1994-11-15       Impact factor: 3.575

8.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

Authors:  A Weidemann; G König; D Bunke; P Fischer; J M Salbaum; C L Masters; K Beyreuther
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

9.  Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody.

Authors:  E H Koo; S L Squazzo; D J Selkoe; C H Koo
Journal:  J Cell Sci       Date:  1996-05       Impact factor: 5.285

10.  Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.

Authors:  J Arribas; J Massagué
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  5 in total

Review 1.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

2.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

Authors:  H Meziane; J C Dodart; C Mathis; S Little; J Clemens; S M Paul; A Ungerer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

Authors:  A Favit; M Grimaldi; T J Nelson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.

Authors:  Dennis Dik-Long Chau; Kristen Wing-Yu Yung; William Wai-Lun Chan; Ying An; Yan Hao; Ho-Yin Edwin Chan; Jacky Chi-Ki Ngo; Kwok-Fai Lau
Journal:  FASEB J       Date:  2019-08-05       Impact factor: 5.191

Review 5.  Targeting Abeta and tau in Alzheimer's disease, an early interim report.

Authors:  Todd E Golde; Leonard Petrucelli; Jada Lewis
Journal:  Exp Neurol       Date:  2009-08-27       Impact factor: 5.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.